C1 Inhibiting Factor
Alternate Names : C1 Esterase Inhibitor
Definition This is a test that measures the concentration of an inhibitor of complement in the blood.
Why is the Test Performed?
Complement activity (CH50, CH100, terminal complement component, or individual complement proteins) is measured to determine if complement is involved in the development of a number of diseases. Complement activity is also measured to monitor severity of a disease or determine efficiency of treatment.
Patients with hereditary angioedema are often depleted of C1 esterase inhibitor.
Today's Top News Stories | • | Clinical Trials Update: Jan. 8, 2009 - Jan 08, 2009, 10:12
- Rheumatoid Arthritis
- Neurologic Disorders
- Seizure Disorders
| • | Hormone Therapy May Cut Colorectal Cancer Risk - Jan 08, 2009, 09:00
Study included nearly 57,000 women who had been followed for about 15 years. | • | New Drug May Work Better Against Chemo Side Effects - Jan 08, 2009, 09:00
Japanese testing reveals longer protection from nausea and vomiting. | • | First Americans Arrived on 2 Separate Paths - Jan 08, 2009, 12:00
Study may explain linguistic and cultural differences of native peoples. | • | Doctors Urged to Screen Diabetics for Sleep Apnea - Jan 08, 2009, 12:00
Treatment may reduce risk of cardiovascular disease |
|
